These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11365133)

  • 1. Major controversies in the DHHS guidelines for use of antiretroviral agents in HIV-infected adults. Department of Health and Human Services.
    Bartlett JG
    Hopkins HIV Rep; 1998 Jan; 10(1):4, 7. PubMed ID: 11365133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV/AIDS treatment guidelines released.
    Randall P
    NIAID AIDS Agenda; 1997 Aug; ():1-2, 12. PubMed ID: 11364605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simply stated...on your mark, get set, go.
    Res Initiat Treat Action; 1998 Jul; 4(4):15. PubMed ID: 11365644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue me.
    Simmons P
    Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient adherence, not viral load now most important in HIV therapy.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(3):6-7. PubMed ID: 11768406
    [No Abstract]   [Full Text] [Related]  

  • 6. The end of AIDS?
    Leland J
    Newsweek; 1996 Dec; 128(23):64-8, 71, 73. PubMed ID: 10162943
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonnucleoside reverse transcriptase inhibitors.
    Murphy RL
    AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV's potent cocktail.
    Lusky K
    Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Another take on when to start and how to succeed.
    Friedland GH
    AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral update.
    PI Perspect; 1996 Nov; (No 20):8-9. PubMed ID: 11363972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-drug regimens may be better.
    AIDS Patient Care STDS; 2000 Dec; 14(12):671. PubMed ID: 11119435
    [No Abstract]   [Full Text] [Related]  

  • 14. A French lesson. French experience shows full funding of treatment advances saves money.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):49. PubMed ID: 11364203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long awaited HIV treatment guidelines released for public comment.
    Crit Path AIDS Proj; 1997; (No 32):1, 9-14. PubMed ID: 11364433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New versions of antiretroviral guidelines contain some important changes.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(4):1-3. PubMed ID: 11810843
    [No Abstract]   [Full Text] [Related]  

  • 17. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
    Murphy RL
    Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage therapy studies.
    Proj Inf Perspect; 1998 Sep; (25):7. PubMed ID: 11365850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV: it's beginning to look like a chronic disease.
    del Rio C
    AIDS Clin Care; 2001 Sep; 13(9):82-3. PubMed ID: 11547601
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
    Patel N; Abdelsayed S; Veve M; Miller CD
    Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.